U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07944534) titled 'Burden of Infections and Antimicrobial Resistance in Neonatal Intensive Care Units in Argentina (PREV-AR NICU): A National Point-Prevalence Study' on Oct. 30.
Brief Summary: PREV-AR NICU was a national, multicenter, cross-sectional point-prevalence study conducted in 58 neonatal intensive care units (NICUs) in Argentina during April 2026. All patients present in a participating NICU during a 24-hour period were included. Active infection was classified as infection without sepsis, probable sepsis, confirmed sepsis, or septic shock. Colonization by multidrug-resistant organisms (MDRO) was assessed by rectal and nasal swabs. Patients ...